Loss-of-function mutations in APOC3, triglycerides, and coronary disease.
Plasma triglyceride levels are heritable and are correlated with the risk of coronary heart disease. Sequencing of the protein-coding regions of the human genome (the exome) has the potential to identify rare mutations that have a large effect on phenotype.We sequenced the protein-coding regions of...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2014
|
| _version_ | 1797072435493732352 |
|---|---|
| author | Crosby, J Peloso, G Auer, P Crosslin, DR Stitziel, N Lange, L Lu, Y Tang, Z Zhang, H Hindy, G Masca, N Stirrups, K Kanoni, S Do, R Jun, G Hu, Y Kang, H Xue, C Goel, A Farrall, M Duga, S Merlini, P Asselta, R Girelli, D Olivieri, O |
| author_facet | Crosby, J Peloso, G Auer, P Crosslin, DR Stitziel, N Lange, L Lu, Y Tang, Z Zhang, H Hindy, G Masca, N Stirrups, K Kanoni, S Do, R Jun, G Hu, Y Kang, H Xue, C Goel, A Farrall, M Duga, S Merlini, P Asselta, R Girelli, D Olivieri, O |
| author_sort | Crosby, J |
| collection | OXFORD |
| description | Plasma triglyceride levels are heritable and are correlated with the risk of coronary heart disease. Sequencing of the protein-coding regions of the human genome (the exome) has the potential to identify rare mutations that have a large effect on phenotype.We sequenced the protein-coding regions of 18,666 genes in each of 3734 participants of European or African ancestry in the Exome Sequencing Project. We conducted tests to determine whether rare mutations in coding sequence, individually or in aggregate within a gene, were associated with plasma triglyceride levels. For mutations associated with triglyceride levels, we subsequently evaluated their association with the risk of coronary heart disease in 110,970 persons.An aggregate of rare mutations in the gene encoding apolipoprotein C3 (APOC3) was associated with lower plasma triglyceride levels. Among the four mutations that drove this result, three were loss-of-function mutations: a nonsense mutation (R19X) and two splice-site mutations (IVS2+1G→A and IVS3+1G→T). The fourth was a missense mutation (A43T). Approximately 1 in 150 persons in the study was a heterozygous carrier of at least one of these four mutations. Triglyceride levels in the carriers were 39% lower than levels in noncarriers (P<1×10(-20)), and circulating levels of APOC3 in carriers were 46% lower than levels in noncarriers (P=8×10(-10)). The risk of coronary heart disease among 498 carriers of any rare APOC3 mutation was 40% lower than the risk among 110,472 noncarriers (odds ratio, 0.60; 95% confidence interval, 0.47 to 0.75; P=4×10(-6)).Rare mutations that disrupt APOC3 function were associated with lower levels of plasma triglycerides and APOC3. Carriers of these mutations were found to have a reduced risk of coronary heart disease. (Funded by the National Heart, Lung, and Blood Institute and others.). |
| first_indexed | 2024-03-06T23:07:36Z |
| format | Journal article |
| id | oxford-uuid:6461467f-14e4-4001-84fa-e15e3923d244 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:07:36Z |
| publishDate | 2014 |
| record_format | dspace |
| spelling | oxford-uuid:6461467f-14e4-4001-84fa-e15e3923d2442022-03-26T18:18:37ZLoss-of-function mutations in APOC3, triglycerides, and coronary disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6461467f-14e4-4001-84fa-e15e3923d244EnglishSymplectic Elements at Oxford2014Crosby, JPeloso, GAuer, PCrosslin, DRStitziel, NLange, LLu, YTang, ZZhang, HHindy, GMasca, NStirrups, KKanoni, SDo, RJun, GHu, YKang, HXue, CGoel, AFarrall, MDuga, SMerlini, PAsselta, RGirelli, DOlivieri, OPlasma triglyceride levels are heritable and are correlated with the risk of coronary heart disease. Sequencing of the protein-coding regions of the human genome (the exome) has the potential to identify rare mutations that have a large effect on phenotype.We sequenced the protein-coding regions of 18,666 genes in each of 3734 participants of European or African ancestry in the Exome Sequencing Project. We conducted tests to determine whether rare mutations in coding sequence, individually or in aggregate within a gene, were associated with plasma triglyceride levels. For mutations associated with triglyceride levels, we subsequently evaluated their association with the risk of coronary heart disease in 110,970 persons.An aggregate of rare mutations in the gene encoding apolipoprotein C3 (APOC3) was associated with lower plasma triglyceride levels. Among the four mutations that drove this result, three were loss-of-function mutations: a nonsense mutation (R19X) and two splice-site mutations (IVS2+1G→A and IVS3+1G→T). The fourth was a missense mutation (A43T). Approximately 1 in 150 persons in the study was a heterozygous carrier of at least one of these four mutations. Triglyceride levels in the carriers were 39% lower than levels in noncarriers (P<1×10(-20)), and circulating levels of APOC3 in carriers were 46% lower than levels in noncarriers (P=8×10(-10)). The risk of coronary heart disease among 498 carriers of any rare APOC3 mutation was 40% lower than the risk among 110,472 noncarriers (odds ratio, 0.60; 95% confidence interval, 0.47 to 0.75; P=4×10(-6)).Rare mutations that disrupt APOC3 function were associated with lower levels of plasma triglycerides and APOC3. Carriers of these mutations were found to have a reduced risk of coronary heart disease. (Funded by the National Heart, Lung, and Blood Institute and others.). |
| spellingShingle | Crosby, J Peloso, G Auer, P Crosslin, DR Stitziel, N Lange, L Lu, Y Tang, Z Zhang, H Hindy, G Masca, N Stirrups, K Kanoni, S Do, R Jun, G Hu, Y Kang, H Xue, C Goel, A Farrall, M Duga, S Merlini, P Asselta, R Girelli, D Olivieri, O Loss-of-function mutations in APOC3, triglycerides, and coronary disease. |
| title | Loss-of-function mutations in APOC3, triglycerides, and coronary disease. |
| title_full | Loss-of-function mutations in APOC3, triglycerides, and coronary disease. |
| title_fullStr | Loss-of-function mutations in APOC3, triglycerides, and coronary disease. |
| title_full_unstemmed | Loss-of-function mutations in APOC3, triglycerides, and coronary disease. |
| title_short | Loss-of-function mutations in APOC3, triglycerides, and coronary disease. |
| title_sort | loss of function mutations in apoc3 triglycerides and coronary disease |
| work_keys_str_mv | AT crosbyj lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT pelosog lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT auerp lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT crosslindr lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT stitzieln lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT langel lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT luy lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT tangz lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT zhangh lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT hindyg lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT mascan lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT stirrupsk lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT kanonis lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT dor lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT jung lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT huy lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT kangh lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT xuec lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT goela lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT farrallm lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT dugas lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT merlinip lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT asseltar lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT girellid lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease AT olivierio lossoffunctionmutationsinapoc3triglyceridesandcoronarydisease |